Zoledronate

You have access
Intravascular Administration of Acridine Orange and Zoledronate in a Bone Metastasis Model of Breast Cancer
RYO SHOJI, HIROYUKI TSUCHIE, HIROYUKI NAGASAWA, MICHIO HONGO, YUJI KASUKAWA, KOJI NOZAKA, DAISUKE KUDO, HIKARU SAITO, KAZUNOBU ABE, SHUN IGARASHI, SHUNTARO HARATA, FUMIHITO KASAMA and NAOHISA MIYAKOSHI

Anticancer Research November 2022, 42 (11) 5357-5363; DOI: https://doi.org/10.21873/anticanres.16041
You have access
Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients With Incurable Pancreatic Cancer
YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI and MASAHIRO YAMAMURA

Anticancer Research February 2022, 42 (2) 1181-1187; DOI: https://doi.org/10.21873/anticanres.15584
You have access
A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients with Incurable Pancreatic Cancer
YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI and MASAHIRO YAMAMURA

Anticancer Research May 2016, 36 (5) 2307-2313;
You have access
Bisphosphonate-related Atypical Femoral Fracture with Bone Metastasis of Breast Cancer: Case Report and Review
KAZUNORI HAYASHI, MASANARI AONO, KOUSUKE SHINTANI and KENICHI KAZUKI

Anticancer Research March 2014, 34 (3) 1245-1249;

Main menu